| 发明名称 |
TREATMENT FOR RHEUMATOID ARTHRITIS |
| 摘要 |
Treatment of rheumatoid arthritis (RA) to provide clinical benefit in patients, including decrease in DAS28-CRP by more than 1.2 and/or improvement determined by ACR20, ACR50 or ACR70, comprising administering therapeutic antibody mavrilimumab. |
| 申请公布号 |
CA2948944(A1) |
申请公布日期 |
2015.11.26 |
| 申请号 |
CA20152948944 |
申请日期 |
2015.05.18 |
| 申请人 |
MEDIMMUNE LIMITED |
发明人 |
CLOSE, DAVID;GODWOOD, ALEX;HOPTON, MARK |
| 分类号 |
A61K39/395;A61P19/02;C07K16/28 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
